IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Esophageal Adenocarcinoma
University of California, Irvinemonoclonal_antibodyPhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 73/ 100
Competitive context
47 Active assets in the Esophageal Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin I-Mab Biopharma US Limited | Phase 3 | BB |
Cetuximab BeOne Medicines | Phase 2 | B |
Capecitabine I-Mab Biopharma US Limited | Phase 3 | B |
Tislelizumab BeOne Medicines | Phase 3 | B |
FLUOROURACILUM I-Mab Biopharma US Limited | Phase 3 | B |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →